221910-88-9

Basic information

• Product Name: BrinzolaMide interMediate
• Synonyms: BrinzolaMide interMediate;(S,E)-Methyl N-(4-hydroxy-2-(3-methoxypropyl)-1,1-dioxido-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazi;Brinzolamide impurity E;(S,E)-Methyl N-(4-hydroxy-2-(3-methoxypropyl)-1,1-dioxido-3,4-dihydro-2H-thieno[3,2-e][1,2]thi;(S,E)-Methyl N-(4-hydroxy-2-(3-methoxypropyl)-1,1-dioxido-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazin-6-yl)sulfonylacetimidate
• CAS NO: 221910-88-9
• Molecular Formula: C13H20N2O7S3
• Molecular Weight: 412.5021
• Mol File: 221910-88-9.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: BrinzolaMide interMediate(CAS DataBase Reference)
• NIST Chemistry Reference: BrinzolaMide interMediate(221910-88-9)
• EPA Substance Registry System: BrinzolaMide interMediate(221910-88-9)

Safety Data

• Hazardous Substances Data: 221910-88-9(Hazardous Substances Data)

Usage

General Description

Brinzolamide intermediate is a chemical compound that is used in the production of the medication brinzolamide, which is a carbonic anhydrase inhibitor. Brinzolamide is primarily used to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The intermediate compound is a key component in the synthesis of brinzolamide and plays a crucial role in the production process. It is a carefully designed chemical that undergoes various reactions and processes to ultimately yield the final active pharmaceutical ingredient, brinzolamide. Due to its importance in the pharmaceutical industry, the intermediate compound is subject to strict quality control and manufacturing standards to ensure the safety and efficacy of the final medication.